NewslettersMesenchymal Cell NewsUncategorizedMesenchymal Stem Cell Treatment Improves Outcome of COVID-19 Patients via Multiple Immunomodulatory MechanismsBy Justin.choi - October 26, 2021013MSC infusion reduced the levels of C-reactive protein, proinflammatory cytokines, and neutrophil extracellular traps, and promoted the maintenance of SARS-CoV-2-specific antibodies.[Cell Research] 7992332 {7992332:BBBBBBBB} apa 50 1 168189 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/Full Article